New York State (NYS) Informed Consent Test List
This is the list of Mayo Medical Laboratories tests that require New York State clients to have informed consent on file to comply with state regulations.
| Mayo Test ID | Test Name |
|---|---|
| FBP1 | 15q Deletion, Type I and Type II Characterization, Prader-Willi/Angelman Syndromes, FISH |
| DUP15 | 15q11.2 Duplication, FISH |
| FP73 | 1p36.3 Microdeletion Syndrome, FISH |
| CYPSP | 21-Hydroxylase Gene (CYP21A2), Full Gene Analysis |
| CYPKP | 21-Hydroxylase Gene (CYP21A2), Known Mutation |
| CAT22 | 22q11.2 Deletion/Duplication, FISH |
| MTHFR | 5,10-Methylenetetrahydrofolate Reductase, Mutation, Blood |
| ACHE_ | Acetylcholinesterase, Amniotic Fluid (AChE-AF), Amniotic Fluid |
| GAABS | Acid Alpha-Glucosidase, Blood Spot |
| AGXMS | AGXT Gene, Full Gene Analysis |
| AGXKM | AGXT Gene, Known Mutation |
| AGXT | Alanine:Glyoxylate Aminotransferase (AGXT) Mutation Analysis (G170R), Blood |
| A1ATR | Alpha-1-Antitrypsin Deficiency Profile |
| FUCT | Alpha-Fucosidase, Fibroblasts |
| FUCW | Alpha-Fucosidase, Leukocytes |
| AGABS | Alpha-Galactosidase, Blood Spot |
| AGA | Alpha-Galactosidase, Leukocytes |
| AGAS | Alpha-Galactosidase, Serum |
| AGPB | Alpha-Globin Gene Analysis |
| IDST | Alpha-L-Iduronidase, Fibroblasts |
| MANT | Alpha-Mannosidase, Fibroblasts |
| MANN | Alpha-Mannosidase, Leukocytes |
| ANAT | Alpha-N-Acetylglucosaminidase, Fibroblasts |
| ANAS | Alpha-N-Acetylglucosaminidase, Serum |
| DALA | Aminolevulinic Acid (ALA), Urine |
| ALADW | Aminolevulinic Acid Dehydratase (ALA-D), Washed Erythrocytes |
| ALAD | Aminolevulinic Acid Dehydratase (ALA-D), Whole Blood |
| AFC | Amniotic Fluid Culture for Genetic Testing |
| AMYL | Amyloidosis, Transthyretin-Associated Familial, DNA Sequence, Blood |
| AMYKM | Amyloidosis, Transthyretin-Associated Familial, Known Mutation |
| TTRX | Amyloidosis, Transthyretin-Associated Familial, Reflex, Blood |
| FPOC | Aneuploidy Detection, Products of Conception (POC), FISH |
| APOB | Apolipoprotein B-100 Molecular Analysis, R3500Q and R3500W |
| APOE | Apolipoprotein E Genotyping, Blood |
| CGH | Array Comparative Genomic Hybridization (aCGH), Whole Genome, Constitutional |
| ARST | Arylsulfatase A, Fibroblasts |
| ARSAW | Arylsulfatase A, Leukocytes |
| ARSU | Arylsulfatase A, Urine |
| ARSB | Arylsulfatase B, Fibroblasts |
| AJP | Ashkenazi Jewish Mutation Analysis Panel With Cystic Fibrosis (CF) |
| AJPWO | Ashkenazi Jewish Mutation Analysis Panel Without Cystic Fibrosis (CF) |
| ARPKD | Autosomal Recessive Polycystic Kidney Disease (ARPKD), Full Gene Analysis |
| ARPKM | Autosomal Recessive Polycystic Kidney Disease (ARPKD), Known Mutation |
| MBCR | BCR/ABL, Translocation 9;22, FISH (D-FISH) |
| BWS | Beckwith-Wiedemann Syndrome (BWS) Methylation Analysis, Blood |
| BGAT | Beta-Galactosidase, Fibroblasts |
| BGA | Beta-Galactosidase, Leukocytes |
| BGLT | Beta-Glucosidase, Fibroblasts |
| BGL | Beta-Glucosidase, Leukocytes |
| BGLR | Beta-Glucuronidase, Fibroblasts |
| BTDMS | Biotinidase Deficiency, BTD Full Gene Analysis |
| BTDKM | Biotinidase Deficiency, BTD Gene, Known Mutation |
| BIOT | Biotinidase, Blood |
| BIOTS | Biotinidase, Serum |
| BLM | Bloom Syndrome, Mutation Analysis, 2281del6/ins7 |
| BTKFP | Bruton's Tyrosine Kinase (BTK) Genotype and Protein Analysis, Full Gene Sequence and Flow Cytometry |
| BTKMP | Bruton's Tyrosine Kinase (BTK) Genotype and Protein Analysis, Known Mutation Sequencing and Flow Cytometry |
| BTKS | Bruton's Tyrosine Kinase (BTK) Genotype, Full Gene Sequence |
| BTKK | Bruton's Tyrosine Kinase (BTK) Genotype, Known Mutation |
| C4U | C4 Acylcarnitine, Quantitative, Urine |
| C5DCU | C5-DC Acylcarnitine, Quantitative, Urine |
| C5OHU | C5-OH Acylcarnitine, Quantitative, Urine |
| CSRKM | Calcium Sensing Receptor (CASR) Gene, Known Mutation |
| CSRMS | Calcium Sensing Receptor (CASR) Gene, Mutation Screen |
| CANW | Canavan Disease, Mutation Analysis, ASPA |
| CDG | Carbohydrate Deficient Transferrin for Congenital Disorders of Glycosylation, Serum |
| COMTO | Catechol-O-Methyltransferase (COMT) Genotype, Saliva |
| COMT | Catechol-O-Methyltransferase Genotype |
| CFTRM | CFTR Gene, Full Gene Analysis |
| CFTRK | CFTR Gene, Known Mutation |
| AF | Chromosome Analysis, Amniotic Fluid |
| POC | Chromosome Analysis, Autopsy, Products of Conception, or Stillbirth |
| CVS | Chromosome Analysis, Chorionic Villus Sampling |
| CMS | Chromosome Analysis, for Congenital Disorders, Blood |
| SCE | Chromosome Analysis, Sister Chromatid Exchange (SCE) for Bloom Syndrome, Blood |
| CTI | Chromosome Analysis, Skin Biopsy |
| FCSP | Chromosome Anomalies, Unspecified Miscellaneous with Chromosome-Specific FISH Probes |
| CRDPU | Creatine Disorders Panel, Urine |
| FCDC | Cri-du-chat Syndrome, 5p15.2 Deletion, FISH |
| CFPB | Cystic Fibrosis Mutation Analysis, 106-Mutation Panel |
| CYSQN | Cystinuria Profile, Quantitative, 24 Hour, Urine |
| CYSR | Cystinuria Profile, Quantitative, Random, Urine |
| 1A2 | Cytochrome P450 1A2 Genotype |
| 1A2O | Cytochrome P450 1A2 Genotype, Saliva |
| 2C19S | Cytochrome P450 2C19 Genotype by Sequence Analysis |
| 2C19O | Cytochrome P450 2C19 Genotype by Sequence Analysis, Saliva |
| 2C9S | Cytochrome P450 2C9 Genotype by Sequence Analysis, Blood |
| 2C9SO | Cytochrome P450 2C9 Genotype by Sequence Analysis, Saliva |
| 2D6 | Cytochrome P450 2D6 Genotype |
| 2D6T | Cytochrome P450 2D6 Genotype for Tamoxifen Hormonal Therapy |
| 2D6TO | Cytochrome P450 2D6 Genotype for Tamoxifen Hormonal Therapy, Saliva |
| 2D6O | Cytochrome P450 2D6 Genotype, Saliva |
| DRPLA | Dentatorubral-Pallidoluysian Atrophy (DRPLA) Gene Analysis |
| MPCR | DNA Analysis B |
| DRD3 | Dopamine Receptor D3 Genotype |
| DRD3O | Dopamine Receptor D3 Genotype, Saliva |
| DRD4 | Dopamine Receptor D4 Genotype (DRD4), Blood |
| DRD4O | Dopamine Receptor D4 Genotype (DRD4), Saliva |
| REVP | Erythrocytosis Evaluation |
| FABMS | Fabry Disease, Full Gene Analysis |
| FABKM | Fabry Disease, Known Mutation |
| F5DNA | Factor V Leiden (R506Q) Mutation, Blood |
| FAPKM | Familial Adenomatous Polyposis (FAP) Known Mutation |
| FAPMS | Familial Adenomatous Polyposis (FAP) Mutation Screen |
| FD | Familial Dysautonomia, Mutation Analysis, IVS20(+6T->C) and R696P |
| LDLRS | Familial Hypercholesterolemia, LDLR Full Gene Sequencing |
| LDLRK | Familial Hypercholesterolemia, LDLR Gene, Known Mutation |
| LDLM | Familial Hypercholesterolemia, LDLR Large Deletion/Duplication, Molecular Analysis |
| ADHP | Familial Hypercholesterolemia/Autosomal Dominant Hypercholesterolemia Genetic Testing Reflex Panel |
| FANCA | Fanconi Anemia C Mutation Analysis, IVS4(+4)A->T and 322delG |
| FAPDB | FAP Large Deletion/Duplication, MLPA |
| FAO | Fatty Acid Oxidation Probe Assay, Fibroblast Culture |
| FBKM | FBN1 Genetic Analysis, Known Mutation |
| FBN1 | FBN1, Full Gene Sequence |
| FBNN | FBN1, Partial Gene Sequence, Neonatal Marfan Syndrome |
| FECHS | Ferrochelatase (FECH) Gene, Full Gene Analysis |
| FECHK | Ferrochelatase (FECH) Gene, Known Mutation |
| FLP | Fetal Lung Profile, Amniotic Fluid |
| FXPB | Fragile X Syndrome, Molecular Analysis |
| FFRBS | Friedreich Ataxia, Frataxin, Quantitative, Blood Spot |
| FFRWB | Friedreich Ataxia, Frataxin, Quantitative, Whole Blood |
| GALK | Galactokinase, Blood |
| GALT | Galactose-1-Phosphate Uridyltransferase (GALT), Blood |
| GALTP | Galactose-1-Phosphate Uridyltransferase Biochemical Phenotyping, Erythrocytes |
| GAL6 | Galactosemia Gene Analysis (6-Mutation Panel) |
| GALTK | Galactosemia Gene Analysis, Known Mutation |
| GCT | Galactosemia Reflex, Blood |
| CBGT | Galactosylceramide Beta-Galactosidase, Fibroblasts |
| CBGC | Galactosylceramide Beta-Galactosidase, Leukocytes |
| GALTM | GALT Gene, Full Gene Analysis |
| GAUW | Gaucher Disease, Mutation Analysis, GBA |
| HHEMO | Hemochromatosis HFE Gene Analysis, Blood |
| HBELC | Hemoglobin Electrophoresis Cascade, Blood |
| HAEVP | Hemolytic Anemia Evaluation |
| HAPB | Hemophilia A, Molecular Analysis for Inversion, Diagnosis and Carrier Detection |
| ACVK | Hereditary Hemorrhagic Telangiectasia, ACVRL1 Gene, Known Mutation |
| HHTP | Hereditary Hemorrhagic Telangiectasia, ENG and ACVRL1 Full Gene Analysis |
| HHTM | Hereditary Hemorrhagic Telangiectasia, ENG and ACVRL1 Large Deletion/Duplication, Molecular Analysis |
| ENGK | Hereditary Hemorrhagic Telangiectasia, ENG Gene, Known Mutation |
| HPKM | Hereditary Pancreatitis, Known Mutation |
| HP | Hereditary Pancreatitis, Mutation Screen |
| MUGS | Hexosaminidase A (MUGS), Serum |
| NAGT | Hexosaminidase A and Total Hexosaminidase, Fibroblasts |
| NAGW | Hexosaminidase A and Total Hexosaminidase, Leukocytes |
| NAGS | Hexosaminidase A and Total Hexosaminidase, Serum |
| NAGR | Hexosaminidase A and Total, Leukocytes/Molecular Reflex |
| HLA15 | HLA-B 1502 Genotype, Carbamazepine Hypersensitivity |
| HL15O | HLA-B 1502 Genotype, Carbamazepine Hypersensitivity, Saliva |
| HLA57 | HLA-B 5701 Genotype, Abacavir Hypersensitivity |
| HL57O | HLA-B 5701 Genotype, Abacavir Hypersensitivity, Saliva |
| HCMM | Homocysteine (Total), Methylmalonic Acid, and Methylcitric Acid, Blood Spots |
| HYOX | Hyperoxaluria Panel, Urine |
| IDNS | Iduronate Sulfatase, Fibroblasts |
| IVD | Isovaleryl-CoA Dehydrogenase (IVD) Mutation Analysis (A282V) |
| FKAL | Kallmann Syndrome, Xp22.3 Deletion, FISH |
| FXYM | Known 45,X, Mosaicism Reflex Analysis, FISH |
| LDSBS | Lysosomal Disorders Screen, Blood Spot |
| MAPTM | MAPT Gene, Sequence Analysis, 7 Exon Screening Panel |
| MAPTK | MAPT Gene, Sequence Analysis, Known Mutation |
| MCC | Maternal Cell Contamination, Molecular Analysis |
| ME2MS | MECP2 Gene, Full Gene Analysis |
| ME2KM | MECP2 Gene, Known Mutation |
| MECDB | MECP2 Large Deletion/Duplication, MLPA |
| MCADP | Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency Molecular Profile |
| MCADK | Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency, Known Mutation |
| MEVP | Methemoglobinemia Evaluation |
| MMAAF | Methylmalonic Acid (MMA), Amniotic Fluid |
| MAHMS | Methylmalonic Aciduria and Homocystinuria, cblC Type, Full Gene Analysis |
| MAHKM | Methylmalonic Aciduria and Homocystinuria, cblC Type, Known Mutation |
| FMDL | Miller-Dieker Syndrome, 17p13.3 Deletion, FISH |
| MLHKM | MLH1 Known Mutation |
| MLHMS | MLH1 Mutation Screen |
| MLHDB | MLH1/MSH2 Large Deletion/Duplication, MLPA |
| MLH12 | MLH1/MSH2 Mutation Screen |
| MCDMS | MLYCD Gene, Full Gene Analysis |
| MCDKM | MLYCD Gene, Known Mutation |
| MSH2K | MSH2 Known Mutation |
| MSH2M | MSH2 Mutation Screen |
| MSH6K | MSH6 Known Mutation |
| MSH6M | MSH6 Mutation Screen, Blood |
| MCIV | Mucolipidosis IV, Mutation Analysis, IVS3(-2)A->G and del6.4kb |
| MENKM | Multiple Endocrine Neoplasia Type 2 (2A, 2B, FMTC) Known Mutation |
| MENMS | Multiple Endocrine Neoplasia Type 2 (2A, 2B, FMTC) Mutation Screen |
| MYH | MYH Gene Analysis for Multiple Adenoma, Y165C and G382D |
| G6ST | N-Acetylgalactosamine-6-Sulfate Sulfatase, Fibroblasts |
| NAT2 | N-Acetyltransferase 2 Gene (NAT2), Full Gene Sequence |
| NAT2O | N-Acetyltransferase 2 Gene (NAT2), Full Gene Sequence, Saliva |
| NARC | Narcolepsy Associated Antigen, Blood |
| NEURF | Neuraminidase, Fibroblasts |
| NAD | Newborn Aneuploidy Detection, FISH |
| NPD | Niemann-Pick Disease, Types A and B, Mutation Analysis |
| NIEM | Niemann-Pick Type C Detection, Fibroblasts |
| NPCKM | Niemann-Pick Type C Disease, Known Mutation |
| NPCMS | Niemann-Pick Type C, Full Gene Analysis |
| NPCDB | NPC Large Deletion/Duplication, MLPA |
| OPRM1 | Opioid Receptor, Mu 1 (OPRM1) Genotype for Naltrexone Efficacy |
| OPRMO | Opioid Receptor, Mu 1 (OPRM1) Genotype for Naltrexone Efficacy, Saliva |
| PKU | Phenylalanine and Tyrosine, Plasma |
| PMMIF | Phosphomannomutase (PMM) and Phosphomannose Isomerase (PMI), Fibroblasts |
| PMMIL | Phosphomannomutase (PMM) and Phosphomannose Isomerase (PMI), Leukocytes |
| PIPA | Pipecolic Acid, Serum |
| PIPU | Pipecolic Acid, Urine |
| GAAMS | Pompe Disease, Full Gene Sequencing |
| GAAKM | Pompe Disease, Known Mutation |
| PBGDW | Porphobilinogen (PBG) Deaminase, Washed Erythrocytes |
| PBGU | Porphobilinogen, Quantitative, Random, Urine |
| PEWE | Porphyrins Evaluation, Washed Erythrocytes |
| PEE | Porphyrins Evaluation, Whole Blood |
| FQPPS | Porphyrins, Feces |
| PWDNA | Prader-Willi/Angelman Syndrome, Molecular Analysis |
| PAD | Prenatal Aneuploidy Detection, FISH |
| GRNMS | Progranulin Gene (GRN), Full Gene Analysis |
| GRNKM | Progranulin Gene (GRN), Known Mutation |
| PTNT | Prothrombin G20210A Mutation, Blood |
| PPFWE | Protoporphyrins, Fractionation, Washed Erythrocytes |
| PPFE | Protoporphyrins, Fractionation, Whole Blood |
| PT1K | PTPN11 Gene, Known Mutation, Blood |
| PT11 | PTPN11, Full Gene Sequence, Blood |
| PTP22 | PTPN22 Genotype, 1858C->T |
| PUPY | Purine and Pyrimidine Panel, Urine |
| PDHC | Pyruvate Dehydrogenase Complex (PDHC), Fibroblasts |
| HTR2 | Serotonin Receptor Genotype (HTR2A and HTR2C) |
| HTR2O | Serotonin Receptor Genotype (HTR2A and HTR2C), Saliva |
| HTT | Serotonin Transporter Genotype, Blood |
| HTTO | Serotonin Transporter Genotype, Saliva |
| FSRY | Sex-Determining Region Y, Yp11.3 Deletion, FISH |
| SCADK | Short-Chain Acyl-CoA Dehydrogenase (SCAD) Deficiency, Known Mutation |
| SCADM | Short-Chain Acyl-CoA Dehydrogenase (SCAD) Deficiency, Mutation Screen |
| SLO | Smith-Lemli-Opitz Screen, Plasma |
| FSMS | Smith-Magenis/Potocki-Lupski Syndromes, 17p11.2 Deletion/Duplication, FISH |
| SPCID | Specimen Source Identification |
| SPHT | Sphingomyelinase, Fibroblasts |
| SBMA | Spinobulbar Muscular Atrophy (Kennedy's Disease), Molecular Analysis |
| FSTS | Steroid Sulfatase Deficiency, Xp22.3 Deletion, FISH |
| STER | Sterols, Plasma |
| FRTEL | Subtelomeric Region Anomalies, FISH |
| SDHSP | Succinate Dehydrogenase (SDH) Gene Analysis |
| SDHDD | Succinate Dehydrogenase (SDH) Gene, Deletion Detection |
| SDHKM | Succinate Dehydrogenase (SDH) Gene, Known Mutation |
| SDHSB | Succinate Dehydrogenase (SDH) Subunit B Gene Analysis |
| SDHSC | Succinate Dehydrogenase (SDH) Subunit C Gene Analysis |
| SDHSD | Succinate Dehydrogenase (SDH) Subunit D Gene Analysis |
| HEXMS | Tay-Sachs Disease, HEXA Gene, Full Gene Analysis |
| HEXKM | Tay-Sachs Disease, HEXA Gene, Known Mutation |
| TSD | Tay-Sachs Disease, Mutation Analysis, HEXA |
| TGFK1 | TGFBR1 Gene, Known Mutation |
| TGF1 | TGFBR1, Full Gene Sequence |
| TGFK2 | TGFBR2 Gene, Known Mutation |
| TGF2 | TGFBR2, Full Gene Sequence |
| THEVP | Thalassemia and Hemoglobinopathy Evaluation |
| THRMP | Thrombophilia Profile |
| TACIF | Transmembrane Activator and CAML Interactor (TACI) Gene, Full Gene Analysis |
| TACIG | Transmembrane Activator and CAML Interactor (TACI) Gene, Known Mutation Analysis |
| TPPTF | Tripeptidyl Peptidase 1 (TPP1) and Palmitoyl-Protein Thioesterase 1 (PPT1), Fibroblasts |
| TPPTL | Tripeptidyl Peptidase 1 (TPP1) and Palmitoyl-Protein Thioesterase 1 (PPT1), Leukocytes |
| UGTK | UDP-Glucuronosyl Transferase 1A1 (UGT1A1) Gene, Known Mutation |
| UGTKO | UDP-Glucuronosyl Transferase 1A1 (UGT1A1) Gene, Known Mutation, Saliva |
| UGT2 | UDP-Glucuronosyl Transferase 1A1 (UGT1A1), Full Gene Sequencing, Hyperbilirubinemia |
| UGT2O | UDP-Glucuronosyl Transferase 1A1 (UGT1A1), Full Gene Sequencing, Hyperbilirubinemia, Saliva |
| UGTI | UDP-Glucuronosyl Transferase 1A1 (UGT1A1), Full Gene Sequencing, Irinotecan Hypersensitivity |
| UGTIO | UDP-Glucuronosyl Transferase 1A1 (UGT1A1), Full Gene Sequencing, Irinotecan Hypersensitivity, Saliva |
| U1A1 | UDP-Glucuronosyl Transferase 1A1 TA Repeat Genotype, UGT1A1 |
| U1A1O | UDP-Glucuronosyl Transferase 1A1 TA Repeat Genotype, UGT1A1, Saliva |
| UPD | Uniparental Disomy |
| UPGDW | Uroporphyrinogen Decarboxylase (UPG D), Washed Erythrocytes |
| UPGD | Uroporphyrinogen Decarboxylase (UPG D), Whole Blood |
| UPGC | Uroporphyrinogen III Synthase (Co-Synthase) (UPG III S), Erythrocytes |
| VLCMS | Very Long Chain Acyl-CoA Dehydrogenase Deficiency, Full Gene Analysis |
| VLCKM | Very Long Chain Acyl-CoA Dehydrogenase Deficiency, Known Mutation |
| VHLD | Von Hippel-Lindau (VHL) Deletion Detection |
| VHLSP | Von Hippel-Lindau (VHL) Gene, Full Gene Analysis |
| VHLKP | Von Hippel-Lindau (VHL) Gene, Known Mutation |
| VWD2N | von Willebrand Disease 2N (Subtype Normandy), Blood |
| WARFP | Warfarin Sensitivity Genotype by Sequence Analysis, Blood |
| WARFO | Warfarin Sensitivity Genotype by Sequence Analysis, Saliva |
| WSCR | Williams Syndrome, 7q11.23 Deletion, FISH |
| WDKM | Wilson Disease Known Mutation, ATP7B DNA Sequencing |
| WDMS | Wilson Disease Mutation Screen, ATP7B DNA Sequencing |
| FWHS | Wolf-Hirschhorn Syndrome, 4p16.3 Deletion, FISH |
| FBUCC | X and Y Aneuploidy Detection, Buccal Smear, FISH |
| FXIST | X-Inactivation (XIST), Xq13.2 Deletion, FISH |
| XAN | Xanthine and Hypoxanthine, Urine |
| YMICR | Y Chromosome Microdeletions, Molecular Detection |
| ZYG | Zygosity Testing (Multiple Births) |
External
link
PDF
document
Excel
document
Word
document